search
Back to results

Timing of Coronary Angiography in NSTE-ACS With ADHF (EARLY-HF)

Primary Purpose

Heart Failure, Acute Coronary Syndrome

Status
Active
Phase
Not Applicable
Locations
Korea, Republic of
Study Type
Interventional
Intervention
Immediate coronary angiography within 2 hours after randomization
Delayed coronary angiography after stabilization of heart failure
Sponsored by
Chonnam National University Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Heart Failure focused on measuring Heart Failure, Acute Coronary Syndrome, Non-ST-Segment Elevation Acute Coronary Syndrome, Myocardial Infarction, Coronary Disease, Cardiovascular Diseases, Heart Diseases

Eligibility Criteria

19 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Age more than 18 years old
  2. NSTE-ACS*
  3. Pulmonary congestion or edema on chest X-ray

    • The definition of NSTE-ACS

Among patients with typical angina, dyspnea or chest discomfort without definite non-cardiac causes, at least 1 presentations of angina that suggest a NSTE-ACS:

  1. Rest angina, which is usually more than 20 minutes in duration
  2. New onset angina that markedly limits physical activity
  3. Increasing angina that is more frequent, longer in duration, or occurs with less exertion than previous angina

A 12-lead electrocardiogram should have no ST-segment elevation. Cardiac troponin may elevate (non-ST-segment elevation myocardial infarction) or not elevate (unstable angina pectoris).

Exclusion Criteria:

1) Cardiogenic shock* 2) Heart failure of other causes rather than NSTE-ACS 3) Terminal malignancy 4) Life expentancy < 1 year 5) Pregnancy or lactation

* The definition of cardiogenic shock All these criteria should be met

  1. Systolic blood pressure < 90 mmHg for 30 minutes, or needing inotropics or vasopressor to maintain systolic blood pressure > or = 90 mmHg
  2. Pulmonary congestion on chest X-ray or increased left ventricular filling pressure by cardiac catheterization
  3. At least one criteria of organ dysfunction - mental obtundation, clammy ski, ogliuria, renal dysfunction, increased level of blood lactate

Sites / Locations

  • Chonnam National University Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Immediate coronary angiography group

Delayed coronary angiography group

Arm Description

Immediate coronary angiography group will routinely receive coronary angiography within 2 hours after randomization.

Delayed coronary angiography group will receive coronary angiography during hospitalization after stabilization of symptoms and signs of heart failure.

Outcomes

Primary Outcome Measures

Cumulative incidence rate of all-cause death, non-fatal myocardial infarction or recurrent ischemia
Cumulative incidence rate of all-cause death, non-fatal myocardial infarction or recurrent ischemia

Secondary Outcome Measures

Rate of all-cause death, non-fatal myocardial infarction or recurrent ischemia
All-cause death, non-fatal myocardial infarction or recurrent ischemia during initial hospitalization
In-hospital mortality
All-cause mortality during initial hospitalization
In-hospital cardiac mortality
Cardiac mortality during initial hospitalization
Rate of procedural complications during coronary angiography or percutaneous coronary intervention
Rate of procedural complications during coronary angiography or percutaneous coronary intervention during initial hospitalization
Peak level of troponin-I
Peak level of troponin-I during initial hospitalization
Rate of recurrent ischemia
Rate of recurrent ischemia during initial hospitalization
Rate of Non-fatal myocardial infarction
Non-fatal myocardial infarction during initial hospitalization
Rate of stroke
Rate of stroke during initial hospitalization
Usage rate of non-invasive positive pressure ventilation
Usage rate of non-invasive positive pressure ventilation during initial hospitalization
Usage rate of mechanical ventilator
Usage rate of mechanical ventilator during initial hospitalization
Usage rate of renal replacement therapy
Usage rate of renal replacement therapy during initial hospitalization
Usage rate of mechanical circulatory support
Usage rate of mechanical circulatory support during initial hospitalization
Rate of acute kidney injury
Rate of acute kidney injury during initial hospitalization
Rate of stent thrombosis
Rate of stent thrombosis during initial hospitalization
Rate of major bleeding
Rate of major bleeding during initial hospitalization (BARC classificiation 3-5)
Duration of initial hospitalization
Duration of initial hospitalization (days)
Cumulative incidence rate of all-cause death, non-fatal myocardial infarction or recurrent ischemia
Cumulative incidence rate of all-cause death, non-fatal myocardial infarction or recurrent ischemia
Cumulative incidence rate of all-cause death
Cumulative incidence rate of all-cause death
Cumulative incidence rate of cardiac death
Cumulative incidence rate of cardiac death
Cumulative incidence rate of rehospitalization due to heart failure
Cumulative incidence rate of rehospitalization due to heart failure
Cumulative incidence rate of cardiogenic shock
Cumulative incidence rate of cardiogenic shock
Cumulative incidence rate of stroke
Cumulative incidence rate of stroke
Cumulative incidence rate of stent thrombosis
Cumulative incidence rate of stent thrombosis
Cumulative incidence rate of major bleeding (BARC classification 3-5)
Cumulative incidence rate of major bleeding (BARC classification 3-5)
Cumulative incidence rate of recurrent ischemia
Cumulative incidence rate of recurrent ischemia
Cumulative incidence rate of non-fatal myocardial infarction
Cumulative incidence rate of non-fatal myocardial infarction
Cumulative incidence rate of all unplanned revascularization
Cumulative incidence rate of all unplanned revascularization
Cumulative incidence rate of all-cause death
Cumulative incidence rate of all-cause death
Cumulative incidence rate of cardiac death
Cumulative incidence rate of cardiac death
Cumulative incidence rate of rehospitalization due to heart failure
Cumulative incidence rate of rehospitalization due to heart failure
Cumulative incidence rate of cardiogenic shock
Cumulative incidence rate of cardiogenic shock
Cumulative incidence rate of stroke
Cumulative incidence rate of stroke
Cumulative incidence rate of stent thrombosis
Cumulative incidence rate of stent thrombosis
Cumulative incidence rate of major bleeding (BARC classification 3-5)
Cumulative incidence rate of major bleeding (BARC classification 3-5)
Cumulative incidence rate of recurrent ischemia
Cumulative incidence rate of recurrent ischemia
Cumulative incidence rate of non-fatal myocardial infarction
Cumulative incidence rate of non-fatal myocardial infarction
Cumulative incidence rate of all unplanned revascularization
Cumulative incidence rate of all unplanned revascularization

Full Information

First Posted
March 14, 2021
Last Updated
August 31, 2023
Sponsor
Chonnam National University Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT04810806
Brief Title
Timing of Coronary Angiography in NSTE-ACS With ADHF
Acronym
EARLY-HF
Official Title
Immediate Versus Delayed Coronary Angiography in Patients With Non-ST-Segment Acute Coronary Syndrome With Acute Decompensated Heart Failure
Study Type
Interventional

2. Study Status

Record Verification Date
August 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
April 1, 2021 (Actual)
Primary Completion Date
August 31, 2024 (Anticipated)
Study Completion Date
August 31, 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Chonnam National University Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The investigators hypothesized that immediate coronary angiography (CAG) within 2 hours after admission can reduce mortality compared to delayed CAG after stabilization of acute decompensated heart failure (ADHF) in patients with non-ST-segment elevation acute coronary syndrome (NSTE-ACS) complicated by ADHF. Patients with NSTE-ACS complicated by ADHF will be randomized to immediate CAG (coronary angiography < 2 hours after randomization) or delayed CAG after stablization group by 1:1 fashion. This study is a prospective, non-blinded, randomized trial.
Detailed Description
Study objective In this study, investigators aim to compare early coronary angiography (CAG < 2 hours after randomization) and delayed CAG after stabilization of acute decompensated heart failure (ADHF) in patients with acute non-ST-elevation acute coronary syndrome (NSTE-ACS) complicated by ADHF. This study is a prospective, non-blinded, randomized trial. Study background An ADHF is frequently encountered in patients with NSTE-ACS. Although its incidence has been decreased during the decades, it is still high up to 8-12% at initial presentation of NSTE-ACS. Patients with NSTE-ACS complicated by ADHF is also known to be associated with worse in-hospital and long-term clinical outcomes than those without heart failure (HF). Because revascularization could reduce mortality in these patients, it should be done in all patients with NSTE-ACS with ADHF. Current guidelines recommend immediate CAG within 2 hours after admission in patients with NSTE-ACS complicated by ADHF. However, it is difficult to decide the timing of coronary angiography in these high risk patients. Notably, the most of randomized trials about the timing of coronary angiography in NSTE-ACS excluded these high risk patients, therefore there is lack of evidence for immediate coronary angiography within 2 hours after admission in patients with NSTE-ACS complicated by ADHF. Investigators will compare immediate CAG within 2 hours after admission and delayed CAG after stabilization of ADHF in patients with NSTE-ACS complicated by ADHF by randomized controlled trial. Study hypothesis Immediate CAG within 2 hours after admission can reduce mortality compared to delayed CAG after stabilization of ADHF in patients with NSTE-ACS complicated by ADHF.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Heart Failure, Acute Coronary Syndrome
Keywords
Heart Failure, Acute Coronary Syndrome, Non-ST-Segment Elevation Acute Coronary Syndrome, Myocardial Infarction, Coronary Disease, Cardiovascular Diseases, Heart Diseases

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
316 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Immediate coronary angiography group
Arm Type
Experimental
Arm Description
Immediate coronary angiography group will routinely receive coronary angiography within 2 hours after randomization.
Arm Title
Delayed coronary angiography group
Arm Type
Active Comparator
Arm Description
Delayed coronary angiography group will receive coronary angiography during hospitalization after stabilization of symptoms and signs of heart failure.
Intervention Type
Procedure
Intervention Name(s)
Immediate coronary angiography within 2 hours after randomization
Intervention Description
After achievement of informed consent in patients with NSTE-ACS complicated by ADHF, patients will be screened and randomized. Patients will be randomized to immediate CAG group or delayed CAG group. Immediate CAG group will receive CAG within 2 hours after randomization. Patients will receive treatment methods according to CAG results: percutaneous coronary intervention (PCI), coronary artery bypass graft (CABG) or medical therapy only by operators' discretion.
Intervention Type
Procedure
Intervention Name(s)
Delayed coronary angiography after stabilization of heart failure
Intervention Description
After achievement of informed consent in patients with NSTE-ACS complicated by ADHF, patients will be screened and randomized. Patients will be randomized to immediate CAG group or delayed CAG group. Delayed CAG group will receive CAG after stabilization of ADHF; improvement of symptoms and signs of heart failure. Patients will receive treatment methods according to CAG results: percutaneous coronary intervention (PCI), coronary artery bypass graft (CABG) or medical therapy only by operators' discretion.
Primary Outcome Measure Information:
Title
Cumulative incidence rate of all-cause death, non-fatal myocardial infarction or recurrent ischemia
Description
Cumulative incidence rate of all-cause death, non-fatal myocardial infarction or recurrent ischemia
Time Frame
Up to 12 months
Secondary Outcome Measure Information:
Title
Rate of all-cause death, non-fatal myocardial infarction or recurrent ischemia
Description
All-cause death, non-fatal myocardial infarction or recurrent ischemia during initial hospitalization
Time Frame
Up to 12 months
Title
In-hospital mortality
Description
All-cause mortality during initial hospitalization
Time Frame
Up to 12 months
Title
In-hospital cardiac mortality
Description
Cardiac mortality during initial hospitalization
Time Frame
Up to 12 months
Title
Rate of procedural complications during coronary angiography or percutaneous coronary intervention
Description
Rate of procedural complications during coronary angiography or percutaneous coronary intervention during initial hospitalization
Time Frame
Up to 12 months
Title
Peak level of troponin-I
Description
Peak level of troponin-I during initial hospitalization
Time Frame
Up to 12 months
Title
Rate of recurrent ischemia
Description
Rate of recurrent ischemia during initial hospitalization
Time Frame
Up to 12 months
Title
Rate of Non-fatal myocardial infarction
Description
Non-fatal myocardial infarction during initial hospitalization
Time Frame
Up to 12 months
Title
Rate of stroke
Description
Rate of stroke during initial hospitalization
Time Frame
Up to 12 months
Title
Usage rate of non-invasive positive pressure ventilation
Description
Usage rate of non-invasive positive pressure ventilation during initial hospitalization
Time Frame
Up to 12 months
Title
Usage rate of mechanical ventilator
Description
Usage rate of mechanical ventilator during initial hospitalization
Time Frame
Up to 12 months
Title
Usage rate of renal replacement therapy
Description
Usage rate of renal replacement therapy during initial hospitalization
Time Frame
Up to 12 months
Title
Usage rate of mechanical circulatory support
Description
Usage rate of mechanical circulatory support during initial hospitalization
Time Frame
Up to 12 months
Title
Rate of acute kidney injury
Description
Rate of acute kidney injury during initial hospitalization
Time Frame
Up to 12 months
Title
Rate of stent thrombosis
Description
Rate of stent thrombosis during initial hospitalization
Time Frame
Up to 12 months
Title
Rate of major bleeding
Description
Rate of major bleeding during initial hospitalization (BARC classificiation 3-5)
Time Frame
Up to 12 months
Title
Duration of initial hospitalization
Description
Duration of initial hospitalization (days)
Time Frame
Up to 12 months
Title
Cumulative incidence rate of all-cause death, non-fatal myocardial infarction or recurrent ischemia
Description
Cumulative incidence rate of all-cause death, non-fatal myocardial infarction or recurrent ischemia
Time Frame
Up to 1 month
Title
Cumulative incidence rate of all-cause death
Description
Cumulative incidence rate of all-cause death
Time Frame
Up to 1 month
Title
Cumulative incidence rate of cardiac death
Description
Cumulative incidence rate of cardiac death
Time Frame
Up to 1 month
Title
Cumulative incidence rate of rehospitalization due to heart failure
Description
Cumulative incidence rate of rehospitalization due to heart failure
Time Frame
Up to 1 month
Title
Cumulative incidence rate of cardiogenic shock
Description
Cumulative incidence rate of cardiogenic shock
Time Frame
Up to 1 month
Title
Cumulative incidence rate of stroke
Description
Cumulative incidence rate of stroke
Time Frame
Up to 1 month
Title
Cumulative incidence rate of stent thrombosis
Description
Cumulative incidence rate of stent thrombosis
Time Frame
Up to 1 month
Title
Cumulative incidence rate of major bleeding (BARC classification 3-5)
Description
Cumulative incidence rate of major bleeding (BARC classification 3-5)
Time Frame
Up to 1 month
Title
Cumulative incidence rate of recurrent ischemia
Description
Cumulative incidence rate of recurrent ischemia
Time Frame
Up to 1 month
Title
Cumulative incidence rate of non-fatal myocardial infarction
Description
Cumulative incidence rate of non-fatal myocardial infarction
Time Frame
Up to 1 month
Title
Cumulative incidence rate of all unplanned revascularization
Description
Cumulative incidence rate of all unplanned revascularization
Time Frame
Up to 1 month
Title
Cumulative incidence rate of all-cause death
Description
Cumulative incidence rate of all-cause death
Time Frame
Up to 12 months
Title
Cumulative incidence rate of cardiac death
Description
Cumulative incidence rate of cardiac death
Time Frame
Up to 12 months
Title
Cumulative incidence rate of rehospitalization due to heart failure
Description
Cumulative incidence rate of rehospitalization due to heart failure
Time Frame
Up to 12 months
Title
Cumulative incidence rate of cardiogenic shock
Description
Cumulative incidence rate of cardiogenic shock
Time Frame
Up to 12 months
Title
Cumulative incidence rate of stroke
Description
Cumulative incidence rate of stroke
Time Frame
Up to 12 months
Title
Cumulative incidence rate of stent thrombosis
Description
Cumulative incidence rate of stent thrombosis
Time Frame
Up to 12 months
Title
Cumulative incidence rate of major bleeding (BARC classification 3-5)
Description
Cumulative incidence rate of major bleeding (BARC classification 3-5)
Time Frame
Up to 12 months
Title
Cumulative incidence rate of recurrent ischemia
Description
Cumulative incidence rate of recurrent ischemia
Time Frame
Up to 12 months
Title
Cumulative incidence rate of non-fatal myocardial infarction
Description
Cumulative incidence rate of non-fatal myocardial infarction
Time Frame
Up to 12 months
Title
Cumulative incidence rate of all unplanned revascularization
Description
Cumulative incidence rate of all unplanned revascularization
Time Frame
Up to 12 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
19 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age more than 18 years old NSTE-ACS* Pulmonary congestion or edema on chest X-ray The definition of NSTE-ACS Among patients with typical angina, dyspnea or chest discomfort without definite non-cardiac causes, at least 1 presentations of angina that suggest a NSTE-ACS: Rest angina, which is usually more than 20 minutes in duration New onset angina that markedly limits physical activity Increasing angina that is more frequent, longer in duration, or occurs with less exertion than previous angina A 12-lead electrocardiogram should have no ST-segment elevation. Cardiac troponin may elevate (non-ST-segment elevation myocardial infarction) or not elevate (unstable angina pectoris). Exclusion Criteria: 1) Cardiogenic shock* 2) Heart failure of other causes rather than NSTE-ACS 3) Terminal malignancy 4) Life expentancy < 1 year 5) Pregnancy or lactation * The definition of cardiogenic shock All these criteria should be met Systolic blood pressure < 90 mmHg for 30 minutes, or needing inotropics or vasopressor to maintain systolic blood pressure > or = 90 mmHg Pulmonary congestion on chest X-ray or increased left ventricular filling pressure by cardiac catheterization At least one criteria of organ dysfunction - mental obtundation, clammy ski, ogliuria, renal dysfunction, increased level of blood lactate
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Min Chul Kim, Professor
Organizational Affiliation
Chonnam National University Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Chonnam National University Hospital
City
Gwangju
Country
Korea, Republic of

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Timing of Coronary Angiography in NSTE-ACS With ADHF

We'll reach out to this number within 24 hrs